Abstract
The World Health Organization declared the global monkeypox outbreak a public health emergency of international concern in July 2022. In response, the American Academy of Dermatology and International League of Dermatological Societies expanded the existing COVID-19 Dermatology Registry to become the “AAD/ILDS Dermatology COVID-19, Monkeypox, and Emerging Infections Registry.” The goal of the registry is to rapidly collate cases of monkeypox and other emerging infections and enable prompt dissemination of findings to front-line healthcare workers and other members of the medical community. The registry is now accepting reports of monkeypox cases and cutaneous reactions to monkeypox/smallpox vaccines. The success of this collaborative effort will depend on active case entry by the global dermatology community.
Original language | English (US) |
---|---|
Pages (from-to) | 1278-1280 |
Number of pages | 3 |
Journal | Journal of the American Academy of Dermatology |
Volume | 87 |
Issue number | 6 |
DOIs | |
State | Published - Dec 2022 |
Keywords
- clinical research
- general dermatology
- infectious disease
- medical dermatology
- monkeypox
- vaccine
- virus
ASJC Scopus subject areas
- Dermatology